AKArun Kumar

Arun Kumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arun Kumar has a total of 130 co-authors. Here are the top co-authors by number of shared publications:

  • Champaka Gopal

    Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India

    4 shared publications
  • Nivedita Singh

    Affiliation Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, India

    4 shared publications
  • Radha Mishra

    Department of Developmental Biology and Genetics, Indian Institute of Science, Bangalore, India

    4 shared publications
  • Dhanashree Anil More

    Affiliation Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, India

    3 shared publications
  • Karthik Mallela

    Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India

    3 shared publications
  • Harsha Pulakkat Muralidharan

    Affiliation Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, India

    2 shared publications

Latest Publications

  • Open Access

    An Atlas of Indian Genetic Diversity

    by Krithika Subramanian, Chandrika Bhattacharyya, Pratheusa Machha, Ankit Mukherjee, Devashish Tripathi, Shreya Chakraborty, Sauma Suvra Majumdar, Shouvanik Sengupta, Priyanka Singh, Vinay More, et al.

    India, the most populous country, remains significantly underrepresented in the global genomics landscape. Previous efforts to catalog Indian genetic diversity were limited in scale, scope, and representation. Here, we present the GenomeIndia dataset, comprising whole genome sequences of 9,768 healthy individuals from 83 populations spanning the ethnolinguistic and biogeographic spectrum of India. We identify 129.93 million high-confidence biallelic variants, 44.03 million of which are previously unreported in global databases. In contrast to large populations that show steady population growth and internal homogeneity, we observe low effective population sizes, significant genetic drift, and profound homozygosity in small tribal groups, likely shaped by antiquity, isolation, and endogamy. We report multiple population-specific pharmacogenomic and deleterious variants, necessitating the integration of local genetic architecture and the inclusion of underrepresented South Asian genomes in global reference resources. Finally, we highlight the limited transferability of Eurocentric polygenic scores to Indian populations, and present an imputation panel that outperforms existing resources for both rare and common variants. Together, our work fills a significant gap in the equity of global human genomics, and paves way for precision medicine strategies that will benefit a quarter of the world population.


  • Whole exome sequencing of lung cancer in Indian patients reveals driver genes and novel mutations with therapeutic potential

    by Wendy D’SOuza, K. N. Lokesh, Naresh Mahajan, Radha Mishra, Usha Amirtham, L. K. Rajeev, Arun Kumar

    Lung cancer remains a leading cause of cancer mortality in India, yet its genomic landscape remains understudied. To address this gap, we performed whole-exome sequencing (WES) on tumor and matched blood samples from 47 lung cancer patients [adenocarcinoma (ADC): 30; squamous cell carcinoma (SqCC): 10; and small cell lung cancer (SCLC): 7] to comprehensively analyze somatic mutations across all protein-coding genes. Our analysis revealed novel and recurrent alterations, with MUC4 being the most recurrently mutated gene, and TP53 emerging as the most frequently mutated across subtypes. Shared mutations included MUC4, MUC16, TP53, KMT2C, CDC27, and UBXN11, the latter not previously associated with lung cancer. ADC exhibited the highest mutational diversity, particularly in RTK/MAPK pathway genes (EGFR, KRAS, BRAF, ERBB2, PIK3CG). Notably, EGFR mutations were identified in 26.7% of ADC cases, including exon 19 deletions (5 cases), exon 21 missense mutations (2 cases), and exon 20 insertions (3 cases) and a novel EGFR exon 20 duplication (p.Ser768_Asp770dup). SqCC showed frequent mutations in KMT2D, ARID2, and FBXW7, suggesting a role for epigenetic dysregulation. One SqCC case harbored a rare EGFR p.Glu866Gly mutation. SCLC was enriched for TP53 (43%) and RB1 (14%) mutations, along with alterations in FAT4 and LRP1B. Importantly, therapeutically actionable mutations were identified in 91.5% patients, including those with NCCN-recommended (25.5%) and FDA-approved off-label drug targets (68.1%). These findings underscore the value of WES in uncovering clinically relevant mutations and support the integration of genomic profiling into precision oncology strategies for Indian lung cancer patients.


  • Open Access

    miR-198 targets TOPORS: implications for oral squamous cell carcinoma pathogenesis

    by Pankhuri Kaushik, Radha Mishra, Champaka Gopal, Arun Kumar

    Background: miRNAs play a critical role in the progression of various diseases, including oral squamous cell carcinoma (OSCC), which represents a major health concern and is one of the leading causes for new cancer cases worldwide. The miRNA dysregulation causes havoc and could be attributed to various factors, with epigenetic silencing of tumor suppressor genes being a major contributor to tumorigenesis. In this study, we have explored the tumor suppressive role of miR-198 in OSCC.Methods: The tumor suppressive effect of miR-198 is established using miRNA analysis in OSCC cell lines, patient samples and xenograft nude mice model. The relationship between the miR-198 and TOPORS is explored using bioinformatics analyses, qRT-PCR, dual-luciferase reporter assay, Western blotting and cancer hall marks assays. The hypermethylation of the MIR198 promoter is confirmed using bisulfite sequencing PCR.Results: We have found miR-198 to be upregulated in OSCC cells treated with 5-Azacytidine, a known DNA methyltransferase inhibitor. Upregulation of miR-198 in 5-Azacytidine treated OSCC cells appears to be due to methylation of the MIR198 promoter. Using bioinformatics analysis and dual-luciferase reporter assay, we have identified TOPORS (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase) as a novel gene target for miR-198. miR-198-mediated repression of TOPORS decreases cell proliferation and anchorage-independent growth and enhances apoptosis of OSCC cells, which is dependent on the presence of the 3′UTR in TOPORS. An inverse correlation between the expression levels of miR-198 and TOPORS is observed in OSCC patient samples, highlighting the biological relevance of their interaction. Delivery of a synthetic miR-198 mimic to OSCC cells results in a significant decrease in xenograft size in nude mice, potentiating its use in therapeutics.Conclusions: These results suggest that miR-198 is epigenetically silenced in OSCC, which promotes tumor growth, in part, by upregulating the levels of TOPORS.


  • Open Access

    miR-617 interacts with the promoter of DDX27 and positively regulates its expression: implications for cancer therapeutics

    by Neelanjana Sarkar, Radha Mishra, Champaka Gopal, Arun Kumar

    Background: Pervasive transcription of the eukaryotic genome generates noncoding RNAs (ncRNAs), which regulate messenger RNA (mRNA) stability and translation. MicroRNAs (miRNAs/miRs) represent a group of well-studied ncRNAs that maintain cellular homeostasis. Thus, any aberration in miRNA expression can cause diseases, including carcinogenesis. According to microRNA microarray analyses, intronic miR-617 is significantly downregulated in oral squamous cell carcinoma (OSCC) tissues compared to normal oral tissues.Methods: The miR-617-mediated regulation of DDX27 is established by performing experiments on OSCC cell lines, patient samples, and xenograft nude mice model. Overexpression plasmid constructs, bisulphite sequencing PCR, bioinformatics analyses, RT-qPCR, Western blotting, dual-luciferase reporter assay, and cell-based assays are utilized to delineate the role of miR-617 in OSCC.Results: The present study shows that miR-617 has an anti-proliferative role in OSCC cells and is partly downregulated in OSCC cells due to the hypermethylation of its independent promoter. Further, we demonstrate that miR-617 upregulates DDX27 gene by interacting with its promoter in a dose-dependent and sequence-specific manner, and this interaction is found to be biologically relevant in OSCC patient samples. Subsequently, we show that miR-617 regulates cell proliferation, apoptosis, and anchorage-independent growth of OSCC cells by modulating DDX27 levels. Besides, our study shows that miR-617 exerts its effects through the PI3K/AKT/MTOR pathway via regulating DDX27 levels. Furthermore, the OSCC xenograft study in nude mice shows the anti-tumorigenic potential of miR-617.Conclusion: miR-617-mediated upregulation of DDX27 is a novel mechanism in OSCC and underscores the therapeutic potential of synthetic miR-617 mimics in cancer therapeutics. To the best of our knowledge, miR-617 is the 15th example of a miRNA that upregulates the expression of a protein-coding gene by interacting with its promoter.


  • Open Access

    Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis

    by Dhanashree Anil More, Nivedita Singh, Radha Mishra, Harsha Pulakkat Muralidharan, Kodaganur Srinivas Gopinath, Champaka Gopal, Arun Kumar

    Epigenetic silencing through methylation is one of the major mechanisms for downregulation of tumor suppressor miRNAs in various malignancies. The aim of this study was to identify novel tumor suppressor miRNAs which are silenced by DNA hypermethylation and investigate the role of at least one of these in oral squamous cell carcinoma (OSCC) pathogenesis. We treated cells from an OSCC cell line SCC131 with 5-Azacytidine, a DNA methyltransferase inhibitor, to reactivate tumor suppressor miRNA genes silenced/downregulated due to DNA methylation. At 5-day post-treatment, total RNA was isolated from the 5-Azacytidine and vehicle control-treated cells. The expression of 2,459 mature miRNAs was analysed between 5-Azacytidine and control-treated OSCC cells by the microRNA microarray analysis. Of the 50 miRNAs which were found to be upregulated following 5-Azacytidine treatment, we decided to work with miR-6741-3p in details for further analysis, as it showed a mean fold expression of >4.0. The results of qRT-PCR, Western blotting, and dual-luciferase reporter assay indicated that miR-6741-3p directly targets the oncogene SRSF3 at the translational level only. The tumor-suppressive role of miR-6741-3p was established by various in vitro assays and in vivo study in NU/J athymic nude mice. Our results revealed that miR-6741-3p plays a tumor-suppressive role in OSCC pathogenesis, in part, by directly regulating SRSF3. Based on our observations, we propose that miR-6741-3p may serve as a potential biological target in tumor diagnostics, prognostic evaluation, and treatment of OSCC and perhaps other malignancies.


  • Open Access

    Intronic miR-6741-3p is involved in oral squamous cell carcinoma pathogenesis by targeting the oncogene SRSF3

    by Dhanashree Anil More, Nivedita Singh, Radha Mishra, Harsha Pulakkat Muralidharan, Kodaganur Srinivas Gopinath, Champaka Gopal, Arun Kumar

    Epigenetic silencing through methylation is one of the major mechanisms for downregulation of tumor suppressor miRNAs in various malignancies. The aim of this study was to identify novel tumor suppressor miRNAs which are silenced by DNA hypermethylation and investigate the role of at least one of these in oral squamous cell carcinoma (OSCC) pathogenesis. We treated cells from an OSCC cell line SCC131 with 5-Azacytidine, a DNA methyltransferase inhibitor, to reactivate tumor suppressor miRNA genes silenced/downregulated due to DNA methylation. At 5-day post-treatment, total RNA was isolated from the 5-Azacytidine and vehicle control-treated cells. The expression of 2,459 mature miRNAs was analysed between 5-Azacytidine and control-treated OSCC cells by the microRNA microarray analysis. Of the 50 miRNAs which were found to be upregulated following 5-Azacytidine treatment, we decided to work with miR-6741-3p in details for further analysis, as it showed a mean fold expression of >4.0. The results of qRT-PCR, Western blotting, and dual-luciferase reporter assay indicated that miR-6741-3p directly targets the oncogene SRSF3 at the translational level only. The tumor-suppressive role of miR-6741-3p was established by various in vitro and in vivo assays. Our results revealed that miR-6741-3p plays a tumor-suppressive role in OSCC pathogenesis, in part, by directly regulating SRSF3 . Based on our observations, we propose that miR-6741-3p may serve as a potential biological target in tumor diagnostics, prognostic evaluation, and treatment of OSCC and perhaps other malignancies.

  • Open Access

    A simple and cost effective method to detect adulteration in ghee with vegetable oils through microscopic examination of sterols

    by Arun Kumar, Darshan Lal, Raman Seth

    Plant sterols together called as phytosterols, and animal sterols mainly cholesterol differ from each other in their crystal shapes, apart from other differences in terms of chemical structure, melting points, etc. When viewed under the microscope, after their isolation from the samples in purified state, the of phytosterols crystals appear hexagonal in shape while those of cholesterol acquire parallelogram shape. But the mixture of phytosterols and cholesterol shows the crystal structure with re-entry angle (Swallow’s tail).On the basis of this characteristic crystal shape, detection of vegetable oils in milk fat up to a level of 15 percent could be confirmed with this simple cost effective method . However, this approach cannot be applied for the detection of body fats in milk fat because of the existence of common sterol (cholesterol) in them.

  • The non‐canonical nuclear functions of key players of the PI3K‐AKT‐MTOR pathway

    by Sakshi Gupta, Mukund Kumar, Soumi Chaudhuri, Arun Kumar

    The PI3K‐AKT‐MTOR signal transduction pathway is one of the essential signalling cascades within the cell due to its involvement in many vital functions. The pathway initiates with the recruitment of phosphatidylinositol‐3 kinases (PI3Ks) onto the plasma membrane, generating phosphatidylinositol‐3,4,5‐triphosphate [PtdIns(3,4,5)P3] and subsequently activating AKT. Being the central node of the PI3K network, AKT activates the mechanistic target of rapamycin kinase complex 1 (MTORC1) via Tuberous sclerosis complex 2 inhibition in the cytoplasm. Although the cytoplasmic role of the pathway has been widely explored for decades, we now know that most of the effector molecules of the PI3K axis diverge from the canonical route and translocate to other cell organelles including the nucleus. The presence of phosphoinositides (PtdIns) inside the nucleus itself indicates the existence of a nuclear PI3K signalling. The nuclear localization of these signaling components is evident in regulating many nuclear processes like DNA replication, transcription, DNA repair, maintenance of genomic integrity, chromatin architecture, and cell cycle control. Here, our review intends to present a comprehensive overview of the nuclear functions of the PI3K‐AKT‐MTOR signaling biomolecules.